Holen Sie sich die Stockscreener-App
2.99
4.17%
-0.13
Handel nachbörslich:
2.99
Schlusskurs vom Vortag:
$3.12
Offen:
$3.145
24-Stunden-Volumen:
7,868
Relative Volume:
0.30
Marktkapitalisierung:
$31.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.94%
1M Leistung:
-26.89%
6M Leistung:
-50.17%
1J Leistung:
-33.70%
1-Tages-Spanne:
$2.95
$3.145
1-Wochen-Bereich:
$2.95
$3.38
52-Wochen-Spanne:
$2.95
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Firmenname
Serina Therapeutics Inc
Sektor
Branche
Telefon
(256) 327-9630
Adresse
601 GENOME WAY, HUNTSVILLE
Vergleichen Sie SER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.99 | 33.27M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | H.C. Wainwright | Buy |
Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten
Serina Therapeutics CSO Moreadith sells $11,519 in stock By Investing.com - Investing.com Nigeria
Serina Therapeutics CSO Moreadith sells $11,519 in stock - Investing.com
Serina Therapeutics Holds 2025 Annual Stockholders Meeting - MSN
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry - The Manila Times
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program - The Manila Times
Serina Therapeutics (NYSE American: SER) responds to FDA clinical hold, targets Q1 2026 SER-252 Phase 1b start - Stock Titan
Serina Therapeutics Submits Response to FDA for SER-252 Program - TradingView — Track All Markets
Serina Therapeutics (NYSE: SER) files complete FDA hold response for SER-252 Parkinson's program - Stock Titan
Is Serina Therapeutics Inc. stock a defensive play amid uncertaintyWall Street Watch & Verified Momentum Watchlists - Newser
Will Serina Therapeutics Inc. stock sustain bullish trend into 2025Earnings Miss & Fast Gain Stock Trading Tips - Newser
How strong is Serina Therapeutics Inc. stock earnings growthJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser
How Serina Therapeutics Inc. stock moves in volatile trading sessionsWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
How Serina Therapeutics Inc. (2BO) stock valuation compares with sectorM&A Rumor & Weekly High Conviction Ideas - Newser
Will Serina Therapeutics Inc. stock profit from fiscal stimulusCEO Change & Verified Short-Term Plans - Newser
Serina Therapeutics CSO Moreadith sells $23k in shares By Investing.com - Investing.com Canada
Why Serina Therapeutics Inc. (2BO) stock benefits from AI revolutionMarket Risk Summary & Capital Efficient Trading Techniques - Newser
Will Serina Therapeutics Inc. stock hit analyst forecastsJuly 2025 Levels & Verified Swing Trading Watchlist - Newser
Why Serina Therapeutics Inc. stock is favored by hedge funds2025 Pullback Review & Risk Controlled Daily Plans - Newser
Why Serina Therapeutics Inc. stock appears on watchlistsJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Is Serina Therapeutics Inc. (2BO) stock cheap vs fundamentals2025 Fundamental Recap & Low Risk Growth Stock Ideas - Newser
Serina Therapeutics (SER) Stock Analysis Report | Financials & Insights - Benzinga
Why analysts raise outlook for Serina Therapeutics Inc. (2BO) stockPortfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser
Is Serina Therapeutics Inc 2BO a good long term investmentRSI Overbought/Oversold & Fast Profit Trading Tips - earlytimes.in
What analysts say about Serina Therapeutics Inc stockFlag and Pennant Patterns & Get Trading Help From Experienced Users - earlytimes.in
What drives Serina Therapeutics Inc stock priceFundamental Stock Analysis & Market-Leading Growth Rates - earlytimes.in
Serina Therapeutics CSO Sells Shares - TradingView
Officer Moreadith Sells 5,965 ($23.3K) Of Serina Therapeutics Inc [SER] - TradingView
Serina Therapeutics insider exercises options, sells 5,965 SER shares - Stock Titan
Serina Therapeutics CSO Moreadith sells $2.1k in shares By Investing.com - Investing.com Nigeria
Serina Therapeutics CSO Moreadith sells $2.1k in shares - Investing.com
Serina Therapeutics Form 4 shows CSO option exercise and sale - Stock Titan
Officer Moreadith Sells 535 ($2.1K) Of Serina Therapeutics Inc [SER] - TradingView
Will Serina Therapeutics Inc. (2BO) stock outperform Dow JonesQuarterly Market Review & Consistent Profit Trading Strategies - newser.com
Will Serina Therapeutics Inc. stock see insider buyingMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Will Serina Therapeutics Inc. (2BO) stock keep high P E multiplesDividend Hike & Safe Capital Growth Plans - newser.com
How Serina Therapeutics Inc. stock benefits from tech adoption2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Why Serina Therapeutics Inc. (2BO) stock trades below fair value2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Can Serina Therapeutics Inc. stock maintain growth trajectoryInsider Buying & Comprehensive Market Scan Insights - newser.com
Why Serina Therapeutics Inc. stock could be next big winner2025 Institutional Moves & Real-Time Volume Analysis - newser.com
Is Serina Therapeutics Inc. stock suitable for passive index fundsWeekly Stock Summary & Expert Curated Trade Setup Alerts - newser.com
Technical signs of recovery in Serina Therapeutics Inc.Portfolio Profit Report & Breakout Confirmation Alerts - newser.com
Should I buy Serina Therapeutics Inc. stock before earnings seasonIPO Watch & Low Drawdown Investment Strategies - newser.com
Moreadith of Serina Therapeutics sells shares worth $24,401 - Investing.com India
Finanzdaten der Serina Therapeutics Inc-Aktie (SER)
Es liegen keine Finanzdaten für Serina Therapeutics Inc (SER) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
1.12%
Kapitalisierung:
|
Volumen (24h):